Alteplase is currently the only approved thrombolytic agent for treatment of acute ischaemic
stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic …

Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large
vessel occlusion. However, in clinical practice, nearly half of the patients do not have …

Background The optimum systolic blood pressure after endovascular thrombectomy for
acute ischaemic stroke is uncertain. We aimed to compare the safety and efficacy of blood …

Background The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with
acute ischemic stroke but who have no evidence of complete occlusion of large or medium …

Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-
LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …

卒中是致残和致死的主要疾病之一, 急性缺血性卒中约占全部卒中的80%.
急性缺血性卒中治疗的关键在于尽早开通阻塞血管, 挽救缺血半暗带. 目前被证实有效的急性缺 …

Endovascular therapy is the first-line treatment for acute ischemic stroke. However, studies
have shown that, even with the timely opening of occluded blood vessels, nearly half of all …

Background and Objective To investigate the efficacy and safety of IV infusion of tirofiban
before endovascular thrombectomy for patients with large vessel occlusion due to …

Background: The effect of imaging selection paradigms on endovascular thrombectomy
outcomes in patients with acute ischemic stroke with large vessel occlusion remains …

Intracranial atherosclerotic disease (ICAD) is one of the most common causes of acute
ischemic stroke worldwide. Patients with acute large vessel occlusion due to underlying …